CLINICAL_TRIALS
research
· 2025-08-26
Clinical Trial Update: A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors [Phase 1]
Summary
This is a Phase 1 clinical trial evaluating the safety and preliminary activity of SHR-4506 injections in adults with malignant tumors, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Malignant Tumors of Adults | Phase 1 | Status: RECRUITING